Promoter holding
64.27%
GL
Geninn Life Sciences Private Limited - Due diligence report
A 360° intelligence report on Geninn Life Sciences Private Limited: trust score, financial health, credit view, compliance, directors, growt…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Geninn Life Sciences Private Limited — 360° Intelligence Report
Generated from MCA filings & public records74/100
Trust Score
Moderate
Geninn Life Sciences Private Limited is assessed as Moderate with a Trust Score of 74/100. Geninn Life Sciences Private Limited is a private limited indian non-government company incorporated in 2019, operating in the Pharma sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.
Report generated on 16 Aug 2026 from the latest processed filings. Geninn Life Sciences Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
74/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
55/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
90/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 4 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
- Negative operating earnings - debt service depends on external support.
- Open charges exceed net worth - secured lenders rank ahead.
- Working-capital cover adequate.
- Profitable - internal accruals available.
Charges position: 3 open (50.64 cr) · 0 satisfied (-).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Hdfc Bank Limited | 2 | 48.0 cr |
| Others | 1 | 48.0 cr |
Compliance Score: 55/100 Moderate
- Company status is "Amalgamated" - not Active.
- Annual filings current (balance sheet Mar 2025).
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| SRINIVAS VASIREDDY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| VENUGOPAL GHANTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 2 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
06
Ownership & Group Intelligence
As per FY 2023 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-
Promoters hold the largest single block of equity - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Vindhya Organics Private Limited | Subsidiary Company | 74.00% |
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 70 · Distress 65
Growth signals & trust indicators
Latest year revenue grew 38%.
Profit expanded 1.42 year-on-year.
Operating for 6 years.
Distress signals & risk flags
Adverse company status: Amalgamated.
Compliance score is weak (55/100).
3 open charge(s) registered - assets are encumbered.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence64/100
Review suggested
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 1 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment61/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 3 open charge(s) of 50.64 cr already registered.
- Compliance gaps should be priced into terms.
Investor view78/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 2 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 12 events24 Sep 2025
Charge created
Hdfc Bank Limited - 16.53 Lakh
18 Jul 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
27 Dec 2022
Director ceased
SRINIVAS VASIREDDY
22 Oct 2022
Director appointed
SRINIVAS VASIREDDY (Director)
05 Jun 2021
Director appointed
VENUGOPAL GHANTA (Director)
Director ceased
KALIDINDI SRIHARI RAJU
Director ceased
HARI BABU BODEPUDI
26 Nov 2020
Director ceased
NARASIMHA REDDY DUTHALA
28 Dec 2019
Charge created
Hdfc Bank Limited - 26.65 cr
06 Dec 2019
Charge created
Others - 23.83 cr
31 Oct 2019
Incorporated
Registered with Roc Hyderabad
10
Key Observations
Auto-generated from the data aboveNet worth is positive.
2 active director(s) / partner(s); board looks stable and experienced.
Promoters hold the largest single block of equity as per the FY 2023 annual return.
| Company | CIN | Location |
|---|---|---|
| Pinkpepper Concepts Private Limited | U24304DL2020PTC371155 | New Delhi, Delhi, India |
| Jay Allied And Chemicals Private Limited | U24110GJ2021PTC124152 | Ahmedabad, Gujarat, India |
| Vidhya Overseas Private Limited | U24233UP2009PTC037125 | Aligarh, Uttar Pradesh, India |
| Mint Nutraceuticals Private Limited | U15131HR2022PTC106100 | Panchkula, Haryana, India |
| Startek Chemicals Limited | U24290GJ2022PLC136602 | Ahmedabad, Gujarat, India |
| Aarogyapure India Private Limited | U72100DL2021PTC378941 | Delhi, Delhi, India |
| Ishwer Ocean Herbal Company Private Limited | U51101HR2013PTC050705 | Panipat, Haryana, India |
| Smn Pharma Private Limited | U24231TN2020PTC134996 | Chennai, Tamil Nadu, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Geninn Life Sciences Private Limited before audits and certifications: compliance score 55/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Geninn Life Sciences Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 70/100, margin trends, ownership structure and peer set for Geninn Life Sciences Private Limited - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Review suggested. Trust score 74/100, distress signals and MSME payment-delay disclosures - know whether Geninn Life Sciences Private Limited pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Geninn Life Sciences Private Limited - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Geninn Life Sciences Private Limited an active company?
Geninn Life Sciences Private Limited has MCA status “Amalgamated” with a compliance score of 55/100 (Moderate).
Is Geninn Life Sciences Private Limited financially healthy?
Geninn Life Sciences Private Limited has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.
Should I do business with Geninn Life Sciences Private Limited?
Its overall Trust Score is 74/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Geninn Life Sciences Private Limited?
Promoters hold the largest single block of equity - exact percentages are in the full report. 2 active director(s) are on record.
Does Geninn Life Sciences Private Limited have loans or charges against its assets?
3 open charge(s) are registered against its assets.
Is Geninn Life Sciences Private Limited up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 55/100 (Moderate).
Is it risky to lend to Geninn Life Sciences Private Limited?
Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
